Bausch Health Companies BHC
NYSE BHC
$6.16 -0.26 (-4.12%)
As of: Sep 9, 2026 · 3:59 PM EDT

Bausch Health Companies (BHC) EBT (2009 - 2026)

Bausch Health Companies' (BHC) quarterly EBT came in at $348.0 million in Q2 2026, up 148.57% year-over-year from $140.0 million in Q2 2025, and up 125.7% quarter-over-quarter from -$1.4 billion in Q1 2026.

Analysis

Bausch Health Companies (BHC) EBT (2009 - 2026) Analysis & Trends

Bausch Health Companies has disclosed EBT across 18 years of filings, most recently posting $348.0 million for Q2 2026.

  • In Q2 2026, EBT rose 148.57% year-over-year to $348.0 million; the TTM figure through Jun 2026 stood at -$732.0 million (down 360.5% YoY), while the FY2025 annual figure was $367.0 million, up 119.76% from the prior year.
  • EBT came in at $348.0 million for Q2 2026 at Bausch Health Companies, up from -$1.4 billion in the prior quarter.
  • In the past five years, EBT ranged from a high of $439.0 million in Q3 2022 to a low of -$1.4 billion in Q1 2026.
  • Average EBT over 5 years is -$55.1 million, with a median of -$14.0 million recorded in 2023.
  • Year-over-year, EBT surged 3085.71% in 2024 and slumped 2780.85% in 2026.
  • Over 5 years, EBT stood at -$357.0 million in 2022, then soared by 98.04% to -$7.0 million in 2023, then surged by 3085.71% to $209.0 million in 2024, then tumbled by 73.21% to $56.0 million in 2025, then jumped by 521.43% to $348.0 million in 2026.
  • Per Business Quant data, the three most recent EBT figures were $348.0 million in Q2 2026, -$1.4 billion in Q1 2026, and $56.0 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT (Qtr)
1 Teva Pharmaceutical Industries 42.84 Bn 39.19 Bn 2.15 Bn -455.00 Mn
2 Viatris 19.13 Bn 18.24 Bn 1.46 Bn -64.00 Mn
3 Dr Reddys Laboratories 9.91 Bn 9.74 Bn 396.53 Mn 58.37 Mn
4 Amneal Pharmaceuticals 5.51 Bn 5.38 Bn 334.51 Mn 70.99 Mn
5 Bausch Health Companies 2.30 Bn 464.50 Mn 2.10 Bn 348.00 Mn
6 Alvotech 1.50 Bn 1.36 Bn 2.56 Mn -66.76 Mn
7 Ani Pharmaceuticals 1.49 Bn 1.13 Bn 165.89 Mn 37.10 Mn
8 Amphastar Pharmaceuticals 1.00 Bn 714.13 Mn 93.47 Mn 38.54 Mn
9 Fennec Pharmaceuticals 402.10 Mn 360.85 Mn 17.15 Mn 2.02 Mn
10 RedHill Biopharma 178.35 Mn 178.35 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 348.00 Mn
Mar 31, 2026 -1.35 Bn
Dec 31, 2025 56.00 Mn
Sep 30, 2025 218.00 Mn
Jun 30, 2025 140.00 Mn
Mar 31, 2025 -47.00 Mn
Dec 31, 2024 209.00 Mn
Sep 30, 2024 -21.00 Mn
Jun 30, 2024 48.00 Mn
Mar 31, 2024 -69.00 Mn
Dec 31, 2023 -7.00 Mn
Sep 30, 2023 -326.00 Mn
Jun 30, 2023 79.00 Mn
Mar 31, 2023 -136.00 Mn
Dec 31, 2022 -357.00 Mn
Sep 30, 2022 439.00 Mn
Jun 30, 2022 -129.00 Mn
Mar 31, 2022 -82.00 Mn
Dec 31, 2021 21.00 Mn
Sep 30, 2021 216.00 Mn